Market Fallers: BRITISH AMERICAN TOBACCO PLC, AstraZeneca plc & GlaxoSmithKline plc

British American Tobacco plc

Shares of BRITISH AMERICAN TOBACCO PLC ADS Common Stock company symbol: LON:BATS has slid -1.63% or -48.5 points throughout the session so far. Traders have not remained optimistic throughout the session. The periods high has already touched 2997.5 dipping to 2913.5. The total volume of shares exchanged so far has reached 751,853 with the daily average at 3,749,105. The 52 week high for the share price is 4265 amounting to 1280.5 points difference from the previous days close and the 52 week low at 2336.5 which is a difference of 648 points. BRITISH AMERICAN TOBACCO PLC ADS Common Stock now has a 20 SMA of 2954.94 and now its 50 day moving average now at 3061.87. The market capitalisation currently stands at £67,345.24m at the time of this report. The currency for this stock is Great British pence.Market cap is measured in GBP. This article was written with the last trade for BRITISH AMERICAN TOBACCO PLC ADS Common Stock being recorded at Tuesday, May 28, 2019 at 12:02:24 PM GMT with the stock price trading at 2936 GBX.


Stock in AstraZeneca plc found using EPIC: LON:AZN has dropped -1.56% or -95 points throughout today’s trading session so far. Investors have so far given a mostly negative outlook during this period. The period high was 6073 and a low of 5982. The total volume of shares exchanged so far has reached 329,342 whilst the average number of shares exchanged is 2,409,434. The 52 week high for the shares is 6540 some 451 points in difference on the previous days close and a 52 week low being 5110 a difference of some 979 points. AstraZeneca plc has a 20 day moving average of 5869.5 and a 50 day simple moving average now of 6071.2. The current market cap is £78,626.85m at the time of this report. The share price is in GBX. Mcap is measured in GBP. This article was written with the last trade for AstraZeneca plc being recorded at Tuesday, May 28, 2019 at 12:02:26 PM GMT with the stock price trading at 5994 GBX.


Stock in GlaxoSmithKline plc company symbol: LON:GSK has slid -1.49% or -23.6 points during today’s session so far. Traders were far from a positive bunch throughout the trading session. The periods high figure was 1571 dipping to 1556.67. The total volume of shares traded by this point was 1,901,721 whilst the daily average number of shares exchanged is just 7,824,620. A 52 week high for the stock is 1648.8 equating to 66.8 points in difference on the previous days close and a 52 week low being 1408.8 which is a variance of 173.2 points. GlaxoSmithKline plc now has a 20 SMA at 1557.61 and also a 50 day moving average now of 1567.48. This puts the market cap at £77,700.05m at the time of this report. The currency for this stock is GBX. Market cap is measured in GBP. This article was written with the last trade for GlaxoSmithKline plc being recorded at Tuesday, May 28, 2019 at 12:02:29 PM GMT with the stock price trading at 1558.4 GBX.

Share on:
Find more news, interviews, share price & company profile here for:
    AstraZeneca and Daiichi Sankyo's Datroway gains FDA approval, offering a new treatment option for specific metastatic breast cancer cases.
    GSK's Jemperli plus chemotherapy gains EU approval for broader use in first-line treatment of advanced or recurrent endometrial cancer, improving survival rates.
    GSK's Shingrix aims for FDA-approved prefilled syringe to simplify shingles vaccination, enhancing convenience for healthcare providers.
    GSK's ADC GSK5764227 gains FDA Breakthrough Therapy status for treating relapsed or refractory osteosarcoma, addressing critical unmet medical needs.
    GSK's Nucala has been approved in China as an add-on treatment for CRSwNP, marking the first anti-IL-5 therapy for adults with this chronic condition.

      Search

      Search